The Indicator from Planet Money Folgen

Drugs used for weight loss like Wegovy, Ozempic and Mounjaro are nearly everywhere in popular culture, but many patients struggling with obesity are still finding them hard to get. On today's show, what's slowing access to these drugs despite their long-term benefits for the economy and patients, and how social conditioning around obesity and excess weight clouds the conversation. Related Episodes:New drugs. Cheaper drugs. Why not both? (Apple / Spotify) For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org. Music by Drop Electric. Find us: TikTok, Instagram, Facebook, Newsletter.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

On the latest edition of Indicators of the week, inflation in the U.S. and Europe is slowing down. Plus, a new report from the Federal Reserve Bank of Boston highlights the number of gig workers typical employment counts miss. And finally ... Red Lobster, endless shrimp and loss leaders. For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org.Music by Drop Electric. Find us: TikTok, Instagram, Facebook, Newsletter. Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

The Supreme Court is set to hear arguments next week on whether the federal government can tax some "unrealized" gains. That's when an asset you hold, rather than sell, gains value. Tax experts say it's the biggest constitutional tax case seen in a century. Today, we lay out the stakes and the massive implications for government revenue, taxpayers, and even wealth inequality.Related Episodes:Could a wealth tax workHow the proposed tax on billionaires would actually workFor sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org. Music by Drop Electric. Find us: TikTok, Instagram, Facebook, Newsletter. Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy